SIRT3 is a major mitochondrial NAD+-dependent protein deacetylase playing important roles in regulating mitochondrial metabolism and energy production and has been linked to the beneficial effects of exercise and caloric restriction. SIRT3 is emerging as a potential therapeutic target to treat metabolic and neurological diseases. We report the first sets of crystal structures of human SIRT3, an apo-structure with no substrate, a structure with a peptide containing acetyl lysine of its natural substrate acetyl-CoA synthetase 2, a reaction intermediate structure trapped by a thioacetyl peptide, and a structure with the dethioacetylated peptide bound. These structures provide insights into the conformational changes induced by the two substrates required for the reaction, the acetylated substrate peptide and NAD+. In addition, the binding study by isothermal titration calorimetry suggests that the acetylated peptide is the first substrate to bind to SIRT3, before NAD+. These structures and biophysical studies provide key insight into the structural and functional relationship of the SIRT3 deacetylation activity. © 2009 by The American Society for Biochemistry and Molecular Biology, Inc.
CITATION STYLE
Jin, L., Wei, W., Jiang, Y., Peng, H., Cai, J., Mao, C., … Perni, R. B. (2009). Crystal structures of human SIRT3 displaying substrate-induced conformational changes. Journal of Biological Chemistry, 284(36), 24394–24405. https://doi.org/10.1074/jbc.M109.014928
Mendeley helps you to discover research relevant for your work.